{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:37:41Z","timestamp":1792427861191,"version":"4.5.0"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1038\/s41574-023-00946-w","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T13:02:43Z","timestamp":1707742963000},"page":"336-348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Thyroid dysfunction in COVID-19"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9813-1126","authenticated-orcid":false,"given":"David Tak Wai","family":"Lui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Cho","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Fan Ngai","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5757-541X","authenticated-orcid":false,"given":"Karen Siu Ling","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,12]]},"reference":[{"key":"946_CR1","unstructured":"World Health Organization. WHO COVID-19 dashboard. WHO https:\/\/covid19.who.int (2023)."},{"key":"946_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"B Hu","year":"2021","unstructured":"Hu, B., Guo, H., Zhou, P. & Shi, Z.-L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 19, 141\u2013154 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"946_CR3","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1530\/JME-22-0036","volume":"69","author":"A Esmaeilzadeh","year":"2022","unstructured":"Esmaeilzadeh, A., Elahi, R., Siahmansouri, A., Maleki, A. J. & Moradi, A. Endocrine and metabolic complications of COVID-19: lessons learned and future prospects. J. Mol. Endocrinol. 69, R125\u2013R150 (2022).","journal-title":"J. Mol. Endocrinol."},{"key":"946_CR4","doi-asserted-by":"publisher","first-page":"dgaa276","DOI":"10.1210\/clinem\/dgaa276","volume":"105","author":"A Brancatella","year":"2020","unstructured":"Brancatella, A. et al. Subacute thyroiditis after Sars-COV-2 infection. J. Clin. Endocrinol. Metab. 105, dgaa276 (2020). This is the very first case of SAT related to COVID-19 reported in the literature.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"946_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.humpath.2006.06.011","volume":"38","author":"L Wei","year":"2007","unstructured":"Wei, L. et al. Pathology of the thyroid in severe acute respiratory syndrome. Hum. Pathol. 38, 95\u2013102 (2007).","journal-title":"Hum. Pathol."},{"key":"946_CR6","doi-asserted-by":"publisher","first-page":"101761","DOI":"10.1016\/j.beem.2023.101761","volume":"37","author":"C Steenblock","year":"2023","unstructured":"Steenblock, C. et al. SARS-CoV-2 infection and its effects on the endocrine system. Best Pract. Res. Clin. Endocrinol. Metab. 37, 101761 (2023).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"946_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133\u2013146 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"946_CR8","doi-asserted-by":"publisher","first-page":"1126637","DOI":"10.3389\/fendo.2023.1126637","volume":"14","author":"E Meftah","year":"2023","unstructured":"Meftah, E. et al. Subacute thyroiditis following COVID-19: a systematic review. Front. Endocrinol. 14, 1126637 (2023).","journal-title":"Front. Endocrinol."},{"key":"946_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12985-023-02103-1","volume":"20","author":"M Ziaka","year":"2023","unstructured":"Ziaka, M. & Exadaktylos, A. Insights into SARS-CoV-2-associated subacute thyroiditis: from infection to vaccine. Virol. J. 20, 132 (2023).","journal-title":"Virol. J."},{"key":"946_CR10","doi-asserted-by":"crossref","first-page":"232470962110094","DOI":"10.1177\/23247096211009412","volume":"9","author":"SE Mathews","year":"2021","unstructured":"Mathews, S. E. et al. Subacute thyroiditis and heart failure in a patient presenting with COVID-19. J. Investig. Med. High Impact Case Rep. 9, 23247096211009412 (2021).","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"946_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.4998","volume":"9","author":"G Houshmand","year":"2021","unstructured":"Houshmand, G., Ghorashi, S. M., Mirrazeghi, F. & Omidi, N. Concomitant active inflammation of myocardium and thyroid, incidental finding in COVID-19 pandemic: a case report. Clin. Case Rep. 9, e04998 (2021).","journal-title":"Clin. Case Rep."},{"key":"946_CR12","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.932321","volume":"22","author":"A Osorio Mart\u00ednez","year":"2021","unstructured":"Osorio Mart\u00ednez, A., Gonz\u00e1lez-Razo, V. T., Navarro-S\u00e1nchez, V., Souto Meiri\u00f1o, C. A. & Ahumada-Ayala, M. SARS-CoV-2-related subacute thyroiditis, myocarditis, and hepatitis after full resolution of COVID-19 serum markers. Am. J. Case Rep. 22, e932321 (2021).","journal-title":"Am. J. Case Rep."},{"key":"946_CR13","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/cncy.22449","volume":"129","author":"R Abreu","year":"2021","unstructured":"Abreu, R., Miguel, R. & Saieg, M. Subacute (De Quervain) thyroiditis during the COVID-19 pandemic. Cancer Cytopathol. 129, 844\u2013846 (2021).","journal-title":"Cancer Cytopathol."},{"key":"946_CR14","first-page":"2019","volume":"66","author":"I Muller","year":"2020","unstructured":"Muller, I. et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 66, 2019\u20132021 (2020). This study described the unique presentation of SARS-CoV-2-related atypical thyroiditis predominantly in patients with severe COVID-19.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"946_CR15","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3390\/v13122447","volume":"13","author":"M Stasiak","year":"2021","unstructured":"Stasiak, M., Zawadzka-Starczewska, K. & Lewi\u0144ski, A. Clinical manifestation of subacute thyroiditis triggered by SARS-CoV-2 infection can be HLA-dependent. Viruses 13, 2447 (2021).","journal-title":"Viruses"},{"key":"946_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12020-022-03197-3","volume":"79","author":"H Bostan","year":"2023","unstructured":"Bostan, H. et al. Impact of the COVID-19 pandemic on the incidence, seasonal distribution, and characteristics of subacute thyroiditis. Endocrine 79, 323\u2013330 (2023).","journal-title":"Endocrine"},{"key":"946_CR17","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1210\/clinem\/dgad235","volume":"108","author":"A Batman","year":"2023","unstructured":"Batman, A. et al. Subacute THYROiditis related to SARS-CoV-2 vaccine and covid-19 (THYROVAC Study): a Multicenter Nationwide Study. J. Clin. Endocrinol. Metab. 108, 1013\u20131026 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"946_CR18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.rce.2021.01.002","volume":"221","author":"M de la Higuera L\u00f3pez-Fr\u00edas","year":"2021","unstructured":"de la Higuera L\u00f3pez-Fr\u00edas, M., Perdomo, C. M. & Galofr\u00e9, J. C. Subacute thyroiditis following COVID-19 infection. Rev. Clin. Esp. 221, 370\u2013372 (2021).","journal-title":"Rev. Clin. Esp."},{"key":"946_CR19","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.4158\/ACCR-2020-0524","volume":"6","author":"MDJ San Juan","year":"2020","unstructured":"San Juan, M. D. J., Florencio, M. Q. V. & Joven, M. H. Subacute thyroiditis in a patient with coronavirus disease 2019. AACE Clin. Case Rep. 6, e361\u2013e364 (2020).","journal-title":"AACE Clin. Case Rep."},{"key":"946_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s12020-021-02841-8","volume":"74","author":"I Pirola","year":"2021","unstructured":"Pirola, I. et al. Incidence of De Quervain\u2019s thyroiditis during the COVID-19 pandemic in an area heavily affected by Sars-CoV-2 infection. Endocrine 74, 215\u2013218 (2021).","journal-title":"Endocrine"},{"key":"946_CR21","doi-asserted-by":"publisher","first-page":"bvab130","DOI":"10.1210\/jendso\/bvab130","volume":"5","author":"A Brancatella","year":"2021","unstructured":"Brancatella, A. et al. Subacute thyroiditis during the SARS-CoV-2 pandemic. J. Endocr. Soc. 5, bvab130 (2021).","journal-title":"J. Endocr. Soc."},{"key":"946_CR22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s40618-021-01718-x","volume":"45","author":"AB Bah\u00e7ecio\u011flu","year":"2022","unstructured":"Bah\u00e7ecio\u011flu, A. B. et al. Subacute thyroiditis during the COVID-19 pandemic: a prospective study. J. Endocrinol. Invest. 45, 865\u2013874 (2022).","journal-title":"J. Endocrinol. Invest."},{"key":"946_CR23","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1089\/thy.2022.0363","volume":"32","author":"HY Ahn","year":"2022","unstructured":"Ahn, H. Y., Choi, H. S., Ha, S. & Cho, S. W. Incidence of subacute thyroiditis during the COVID-19 pandemic in South Korea using the National Health Insurance Service Database. Thyroid 32, 1299\u20131306 (2022).","journal-title":"Thyroid"},{"key":"946_CR24","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1136\/postgradmedj-2021-141429","volume":"99","author":"S Mondal","year":"2022","unstructured":"Mondal, S., DasGupta, R., Lodh, M. & Ganguly, A. Subacute thyroiditis following recovery from COVID-19 infection: novel clinical findings from an Eastern Indian cohort. Postgrad. Med. J. 99, 558\u2013565 (2022).","journal-title":"Postgrad. Med. J."},{"key":"946_CR25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1507\/endocrj.EJ20-0553","volume":"68","author":"S Mizuno","year":"2021","unstructured":"Mizuno, S. et al. A case of postpartum thyroiditis following SARS-CoV-2 infection. Endocr. J. 68, 371\u2013374 (2021).","journal-title":"Endocr. J."},{"key":"946_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-252837","volume":"15","author":"N Nakaizumi","year":"2022","unstructured":"Nakaizumi, N., Fukata, S., Hirokawa, M. & Akamizu, T. Painless thyroiditis incidentally diagnosed following SARS-CoV-2 infection. BMJ Case Rep. 15, e252837 (2022).","journal-title":"BMJ Case Rep."},{"key":"946_CR27","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-8587(15)00225-9","volume":"3","author":"E Fliers","year":"2015","unstructured":"Fliers, E., Bianco, A. C., Langouche, L. & Boelen, A. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol. 3, 816\u2013825 (2015).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"946_CR28","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s40618-020-01366-7","volume":"43","author":"M Mateu-Salat","year":"2020","unstructured":"Mateu-Salat, M., Urgell, E. & Chico, A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves\u2019 disease after COVID-19. J. Endocrinol. Invest. 43, 1527\u20131528 (2020).","journal-title":"J. Endocrinol. Invest."},{"key":"946_CR29","doi-asserted-by":"publisher","first-page":"101742","DOI":"10.1016\/j.beem.2023.101742","volume":"37","author":"A Brancatella","year":"2023","unstructured":"Brancatella, A., Viola, N., Santini, F. & Latrofa, F. COVID-induced thyroid autoimmunity. Best Pract. Res. Clin. Endocrinol. Metab. 37, 101742 (2023).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"946_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.4225","volume":"9","author":"MM Allam","year":"2021","unstructured":"Allam, M. M., El-Zawawy, H. T., Ahmed, S. M. & Aly Abdelhamid, M. Thyroid disease and covid-19 infection: case series. Clin. Case Rep. 9, e04225 (2021).","journal-title":"Clin. Case Rep."},{"key":"946_CR31","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s40618-021-01576-7","volume":"44","author":"G Lanzolla","year":"2021","unstructured":"Lanzolla, G., Marcocci, C. & Marin\u00f2, M. Graves\u2019 disease and Graves\u2019 orbitopathy following COVID-19. J. Endocrinol. Invest. 44, 2011\u20132012 (2021).","journal-title":"J. Endocrinol. Invest."},{"key":"946_CR32","doi-asserted-by":"publisher","first-page":"5827664","DOI":"10.1155\/2022\/5827664","volume":"2022","author":"SYT Tan","year":"2022","unstructured":"Tan, S. Y. T. et al. Acute flaccid tetraparesis after COVID-19 infection: think of the thyroid. Case Rep. Med. 2022, 5827664 (2022).","journal-title":"Case Rep. Med."},{"key":"946_CR33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.5811\/cpcem.2021.5.52692","volume":"5","author":"K Sullivan","year":"2021","unstructured":"Sullivan, K., Helgeson, J. & McGowan, A. COVID-19 associated thyroid storm: a case report. Clin. Pract. Cases Emerg. Med. 5, 412\u2013414 (2021).","journal-title":"Clin. Pract. Cases Emerg. Med."},{"key":"946_CR34","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/cen.14860","volume":"98","author":"DE Barajas Galindo","year":"2023","unstructured":"Barajas Galindo, D. E. et al. Increased incidence of Graves\u2019 disease during the SARS-CoV2 pandemic. Clin. Endocrinol. 98, 730\u2013737 (2023).","journal-title":"Clin. Endocrinol."},{"key":"946_CR35","volume":"14","author":"M Khaja","year":"2022","unstructured":"Khaja, M. et al. Hashimoto\u2019s thyroiditis encephalopathy induced by COVID-19 infection. Cureus 14, e28419 (2022).","journal-title":"Cureus"},{"key":"946_CR36","doi-asserted-by":"publisher","first-page":"bvaa130","DOI":"10.1210\/jendso\/bvaa130","volume":"4","author":"NM Dixit","year":"2020","unstructured":"Dixit, N. M. et al. Sudden cardiac arrest in a patient with myxedema coma and COVID-19. J. Endocr. Soc. 4, bvaa130 (2020).","journal-title":"J. Endocr. Soc."},{"key":"946_CR37","doi-asserted-by":"publisher","first-page":"947594","DOI":"10.3389\/fendo.2022.947594","volume":"13","author":"M Darvishi","year":"2022","unstructured":"Darvishi, M., Nazer, M. R., Shahali, H. & Nouri, M. Association of thyroid dysfunction and COVID-19: a systematic review and meta-analysis. Front. Endocrinol. 13, 947594 (2022).","journal-title":"Front. Endocrinol."},{"key":"946_CR38","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1210\/clinem\/dgaa813","volume":"106","author":"DTW Lui","year":"2021","unstructured":"Lui, D. T. W. et al. Thyroid dysfunction in relation to immune profile, disease status and outcome in 191 patients with COVID-19. J. Clin. Endocrinol. Metab. 106, 926\u2013935 (2021). This cohort study of patients with COVID-19 demonstrates the three common patterns of abnormal thyroid function tests in the context of COVID-19.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"946_CR39","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s40618-021-01506-7","volume":"44","author":"L Croce","year":"2021","unstructured":"Croce, L. et al. The cytokine storm and thyroid hormone changes in COVID-19. J. Endocrinol. Invest. 44, 891\u2013904 (2021).","journal-title":"J. Endocrinol. Invest."},{"key":"946_CR40","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s40618-021-01599-0","volume":"44","author":"R Baldelli","year":"2021","unstructured":"Baldelli, R. et al. Thyroid dysfunction in COVID-19 patients. J. Endocrinol. Invest. 44, 2735\u20132739 (2021).","journal-title":"J. Endocrinol. Invest."},{"key":"946_CR41","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s12020-021-02863-2","volume":"74","author":"V Ilera","year":"2021","unstructured":"Ilera, V. et al. Correlation between inflammatory parameters and pituitary-thyroid axis in patients with COVID-19. Endocrine 74, 455\u2013460 (2021).","journal-title":"Endocrine"},{"key":"946_CR42","doi-asserted-by":"publisher","first-page":"bvab076","DOI":"10.1210\/jendso\/bvab076","volume":"5","author":"LH Duntas","year":"2021","unstructured":"Duntas, L. H. & Jonklaas, J. COVID-19 and thyroid diseases: a bidirectional impact. J. Endocr. Soc. 5, bvab076 (2021).","journal-title":"J. Endocr. Soc."},{"key":"946_CR43","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s40618-022-01806-6","volume":"45","author":"C Okoye","year":"2022","unstructured":"Okoye, C. et al. Is non-thyroidal illness syndrome (NTIS) a clinical predictor of COVID-19 mortality in critically ill oldest old patients? J. Endocrinol. Invest. 45, 1689\u20131692 (2022).","journal-title":"J. Endocrinol. Invest."},{"key":"946_CR44","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1530\/EJE-20-0335","volume":"183","author":"A Lania","year":"2020","unstructured":"Lania, A. et al. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur. J. Endocrinol. 183, 381\u2013387 (2020). This cohort study demonstrates the occurrence of thyrotoxicosis without underlying thyroid autoimmunity in the context of COVID-19.","journal-title":"Eur. J. Endocrinol."},{"key":"946_CR45","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s40618-021-01714-1","volume":"45","author":"C Sparano","year":"2021","unstructured":"Sparano, C. et al. Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS-CoV-2 disease. J. Endocrinol. Invest. 45, 837\u2013847 (2021).","journal-title":"J. Endocrinol. Invest."},{"key":"946_CR46","doi-asserted-by":"publisher","first-page":"645787","DOI":"10.3389\/fendo.2021.645787","volume":"12","author":"L Das","year":"2021","unstructured":"Das, L. et al. Spectrum of endocrine dysfunction and association with disease severity in patients with COVID-19: insights from a cross-sectional, observational study. Front. Endocrinol. 12, 645787 (2021).","journal-title":"Front. Endocrinol."},{"key":"946_CR47","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12020-021-02758-2","volume":"73","author":"A Pizzocaro","year":"2021","unstructured":"Pizzocaro, A. et al. Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study. Endocrine 73, 255\u2013260 (2021).","journal-title":"Endocrine"},{"key":"946_CR48","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1515\/cclm-2021-0511","volume":"59","author":"SF Assimakopoulos","year":"2021","unstructured":"Assimakopoulos, S. F. et al. Low serum TSH in the acute phase of COVID-19 pneumonia: thyrotoxicosis or a face of \u2018non-thyroidal illness syndrome\u2019? Clin. Chem. Lab. Med. 59, e420\u2013e423 (2021).","journal-title":"Clin. Chem. Lab. Med."},{"key":"946_CR49","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1089\/thy.2021.0225","volume":"31","author":"FE Beltr\u00e3o","year":"2021","unstructured":"Beltr\u00e3o, F. E. et al. Thyroid hormone levels during hospital admission inform disease severity and mortality in COVID-19 patients. Thyroid 31, 1639\u20131649 (2021).","journal-title":"Thyroid"},{"key":"946_CR50","doi-asserted-by":"publisher","first-page":"1031188","DOI":"10.3389\/fendo.2022.1031188","volume":"13","author":"R \u015awi\u0105tkowska-Stodulska","year":"2022","unstructured":"\u015awi\u0105tkowska-Stodulska, R., Berli\u0144ska, A. & Puchalska-Regli\u0144ska, E. Thyroglobulin levels in COVID-19-positive patients: correlations with thyroid function tests, inflammatory markers, and glucocorticoid use. Front. Endocrinol. 13, 1031188 (2022).","journal-title":"Front. Endocrinol."},{"key":"946_CR51","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1530\/EC-21-0029","volume":"10","author":"DA Vassiliadi","year":"2021","unstructured":"Vassiliadi, D. A. et al. Thyroid hormone alterations in critically and non-critically ill patients with SARS-CoV-2 infection. Endocr. Connect. 10, 646\u2013655 (2021).","journal-title":"Endocr. Connect."},{"key":"946_CR52","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/cen.14476","volume":"95","author":"DTW Lui","year":"2021","unstructured":"Lui, D. T. W. et al. Role of non-thyroidal illness syndrome in predicting adverse outcomes in COVID-19 patients predominantly of mild-to-moderate severity. Clin. Endocrinol. 95, 469\u2013477 (2021).","journal-title":"Clin. Endocrinol."},{"key":"946_CR53","first-page":"4149","volume":"25","author":"Y Akkoyunlu","year":"2021","unstructured":"Akkoyunlu, Y. et al. Analysis of the involvement of the thyroid gland using computed tomography in patients with suspected SARS-CoV-2 infection: a retrospective study. Eur. Rev. Med. Pharmacol. Sci. 25, 4149\u20134155 (2021).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"946_CR54","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12020-021-02855-2","volume":"74","author":"DTW Lui","year":"2021","unstructured":"Lui, D. T. W. et al. Higher SARS-CoV-2 viral loads correlated with smaller thyroid volumes on ultrasound among male COVID-19 survivors. Endocrine 74, 205\u2013214 (2021).","journal-title":"Endocrine"},{"key":"946_CR55","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s12020-022-03019-6","volume":"76","author":"E Urhan","year":"2022","unstructured":"Urhan, E., Karaca, Z., Kara, C. S., Yuce, Z. T. & Unluhizarci, K. The potential impact of COVID-19 on thyroid gland volumes among COVID-19 survivors. Endocrine 76, 635\u2013641 (2022).","journal-title":"Endocrine"},{"key":"946_CR56","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.15034","volume":"11","author":"MHM Fung","year":"2023","unstructured":"Fung, M. H. M. et al. A prospective follow-up of thyroid volume and thyroiditis features on ultrasonography among survivors of predominantly mild to moderate COVID-19. PeerJ 11, e15034 (2023).","journal-title":"PeerJ"},{"key":"946_CR57","doi-asserted-by":"publisher","first-page":"bqab203","DOI":"10.1210\/endocr\/bqab203","volume":"163","author":"SA Clarke","year":"2022","unstructured":"Clarke, S. A., Abbara, A. & Dhillo, W. S. Impact of COVID-19 on the endocrine system: a mini-review. Endocrinology 163, bqab203 (2022).","journal-title":"Endocrinology"},{"key":"946_CR58","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3390\/biomedicines11020614","volume":"11","author":"A Piekarska","year":"2023","unstructured":"Piekarska, A. et al. The influence of SARS-CoV-2 infection on the thyroid gland. Biomedicines 11, 614 (2023).","journal-title":"Biomedicines"},{"key":"946_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-020-00662-x","volume":"9","author":"M-Y Li","year":"2020","unstructured":"Li, M.-Y., Li, L., Zhang, Y. & Wang, X.-S. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect. Dis. Poverty 9, 45 (2020).","journal-title":"Infect. Dis. Poverty"},{"key":"946_CR60","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s40618-020-01436-w","volume":"44","author":"M Rotondi","year":"2021","unstructured":"Rotondi, M. et al. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J. Endocrinol. Invest. 44, 1085\u20131090 (2021).","journal-title":"J. Endocrinol. Invest."},{"key":"946_CR61","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s12020-021-02807-w","volume":"74","author":"F Coperchini","year":"2021","unstructured":"Coperchini, F. et al. Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: a pilot study. Endocrine 74, 638\u2013645 (2021).","journal-title":"Endocrine"},{"key":"946_CR62","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.3390\/cells10081900","volume":"10","author":"DWL Wong","year":"2021","unstructured":"Wong, D. W. L. et al. Multisystemic cellular tropism of SARS-CoV-2 in autopsies of COVID-19 patients. Cells 10, 1900 (2021).","journal-title":"Cells"},{"key":"946_CR63","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3390\/biology11050697","volume":"11","author":"G-C Park","year":"2022","unstructured":"Park, G.-C. et al. ACE2 and TMPRSS2 immunolocalization and COVID-19-related thyroid disorder. Biology 11, 697 (2022).","journal-title":"Biology"},{"key":"946_CR64","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-22-0074","volume":"11","author":"S Macedo","year":"2022","unstructured":"Macedo, S. et al. Detection of SARS-CoV-2 infection in thyroid follicular cells from a COVID-19 autopsy series. Eur. Thyroid. J. 11, e220074 (2022). This autopsy series demonstrates the evidence of direct SARS-CoV-2 involvement in the thyroid gland.","journal-title":"Eur. Thyroid. J."},{"key":"946_CR65","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/thy.2022.0229","volume":"33","author":"VF Koehler","year":"2023","unstructured":"Koehler, V. F. et al. Thyroidal angiotensin-converting enzyme 2 protein expression and thyroid function tests in patients with COVID-19: results from a retrospective case series and a prospective cohort study. Thyroid 33, 177\u2013185 (2023). This study of thyroid samples shows the high percentage of thyroidal ACE2 expression in deceased patients who had COVID-19, suggesting the possible mechanism for SARS-CoV-2 involvement in the thyroid gland.","journal-title":"Thyroid"},{"key":"946_CR66","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40618-021-01628-y","volume":"45","author":"AM Poma","year":"2021","unstructured":"Poma, A. M. et al. COVID-19 autopsy cases: detection of virus in endocrine tissues. J. Endocrinol. Invest. 45, 209\u2013214 (2021).","journal-title":"J. Endocrinol. Invest."},{"key":"946_CR67","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1089\/thy.2021.0345","volume":"31","author":"AM Poma","year":"2021","unstructured":"Poma, A. M. et al. Activation of type I and type II interferon signaling in SARS-CoV-2-positive thyroid tissue of patients dying from COVID-19. Thyroid 31, 1766\u20131775 (2021).","journal-title":"Thyroid"},{"key":"946_CR68","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-22-0005","volume":"11","author":"H Jakovac","year":"2022","unstructured":"Jakovac, H., Feren\u010di\u0107, A., Stemberger, C., Mohar Vitezi\u0107, B. & Cuculi\u0107, D. Detection of Sars-Cov-2 antigens in thyroid gland showing histopathological features of subacute thyroiditis. Eur. Thyroid. J. 11, e220005 (2022).","journal-title":"Eur. Thyroid. J."},{"key":"946_CR69","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.3390\/biomedicines10112855","volume":"10","author":"G Bellastella","year":"2022","unstructured":"Bellastella, G. et al. Neuroimmunoendocrinology of SARS-CoV 2 infection. Biomedicines 10, 2855 (2022).","journal-title":"Biomedicines"},{"key":"946_CR70","doi-asserted-by":"publisher","first-page":"101752","DOI":"10.1016\/j.beem.2023.101752","volume":"37","author":"C Capatina","year":"2023","unstructured":"Capatina, C., Poiana, C. & Fleseriu, M. Pituitary and SARS CoV-2: an unremitting conundrum. Best Pract. Res. Clin. Endocrinol. Metab. 37, 101752 (2023).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"946_CR71","doi-asserted-by":"publisher","first-page":"1089190","DOI":"10.3389\/fendo.2023.1089190","volume":"14","author":"Z Li","year":"2023","unstructured":"Li, Z. et al. Thyroxine changes in COVID-19 pandemic: a systematic review and meta-analysis. Front. Endocrinol. 14, 1089190 (2023).","journal-title":"Front. Endocrinol."},{"key":"946_CR72","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11154-021-09678-6","volume":"23","author":"B Soldevila","year":"2022","unstructured":"Soldevila, B., Puig-Domingo, M. & Marazuela, M. Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated? Rev. Endocr. Metab. Disord. 23, 137\u2013150 (2022).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"946_CR73","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11154-020-09615-z","volume":"22","author":"L Scappaticcio","year":"2021","unstructured":"Scappaticcio, L., Pitoia, F., Esposito, K., Piccardo, A. & Trimboli, P. Impact of COVID-19 on the thyroid gland: an update. Rev. Endocr. Metab. Disord. 22, 803\u2013815 (2021). This study is a concise summary of the effect of COVID-19 on the thyroid gland.","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"946_CR74","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s11154-021-09648-y","volume":"22","author":"M Stasiak","year":"2021","unstructured":"Stasiak, M. & Lewi\u0144ski, A. New aspects in the pathogenesis and management of subacute thyroiditis. Rev. Endocr. Metab. Disord. 22, 1027\u20131039 (2021). This paper is a comprehensive review of various clinical aspects of SAT, including COVID-19-related SAT.","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"946_CR75","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12020-021-02770-6","volume":"73","author":"AK Murugan","year":"2021","unstructured":"Murugan, A. K. & Alzahrani, A. S. SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves\u2019 disease. Endocrine 73, 243\u2013254 (2021).","journal-title":"Endocrine"},{"key":"946_CR76","doi-asserted-by":"publisher","first-page":"617089","DOI":"10.3389\/fimmu.2020.617089","volume":"11","author":"A Vojdani","year":"2020","unstructured":"Vojdani, A., Vojdani, E. & Kharrazian, D. Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front. Immunol. 11, 617089 (2020).","journal-title":"Front. Immunol."},{"key":"946_CR77","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s40618-022-01896-2","volume":"46","author":"E Colonnello","year":"2023","unstructured":"Colonnello, E. et al. Thyroid hormones and platelet activation in COVID-19 patients. J. Endocrinol. Invest. 46, 261\u2013269 (2023).","journal-title":"J. Endocrinol. Invest."},{"key":"946_CR78","doi-asserted-by":"publisher","first-page":"566439","DOI":"10.3389\/fendo.2020.566439","volume":"11","author":"R Zou","year":"2020","unstructured":"Zou, R. et al. Euthyroid sick syndrome in patients with COVID-19. Front. Endocrinol. 11, 566439 (2020).","journal-title":"Front. Endocrinol."},{"key":"946_CR79","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s40618-020-01460-w","volume":"44","author":"W Gao","year":"2021","unstructured":"Gao, W. et al. Thyroid hormone concentrations in severely or critically ill patients with COVID-19. J. Endocrinol. Invest. 44, 1031\u20131040 (2021).","journal-title":"J. Endocrinol. Invest."},{"key":"946_CR80","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s40618-021-01732-z","volume":"45","author":"DTW Lui","year":"2022","unstructured":"Lui, D. T. W., Lee, C. H. & Lam, K. S. L. Letter to the Editor: \u2019Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS-CoV-2 disease\u2019-prognostic significance of non-thyroidal illness syndrome across the whole spectrum of COVID-19 severity. J. Endocrinol. Invest. 45, 901\u2013902 (2022).","journal-title":"J. Endocrinol. Invest."},{"key":"946_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-021-00766-x","volume":"21","author":"J Gong","year":"2021","unstructured":"Gong, J. et al. Prognostic significance of low TSH concentration in patients with COVID-19 presenting with non-thyroidal illness syndrome. BMC Endocr. Disord. 21, 111 (2021).","journal-title":"BMC Endocr. Disord."},{"key":"946_CR82","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1055\/a-1971-8781","volume":"55","author":"M Sahin","year":"2023","unstructured":"Sahin, M. et al. The clinical characteristics and outcomes of COVID-19 patients with pre-existing thyroid dysfunction: a Nationwide study. Horm. Metab. Res. 55, 25\u201330 (2023).","journal-title":"Horm. Metab. Res."},{"key":"946_CR83","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S2213-8587(21)00028-0","volume":"9","author":"TH Brix","year":"2021","unstructured":"Brix, T. H., Heged\u00fcs, L., Hallas, J. & Lund, L. C. Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism. Lancet Diabetes Endocrinol. 9, 197\u2013199 (2021). A key population-based observational study suggesting that patients treated for hypothyroidism and hyperthyroidism who were infected by SARS-CoV-2 did not fare worse than patients without SARS-CoV-2 infection.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"946_CR84","doi-asserted-by":"publisher","first-page":"7","DOI":"10.21037\/aot-21-8","volume":"6","author":"C Nguyen","year":"2022","unstructured":"Nguyen, C. et al. SARS-CoV-2 infection in patients with thyroid disease: a cross-sectional study. Ann. Thyroid. 6, 7 (2022).","journal-title":"Ann. Thyroid."},{"key":"946_CR85","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3389\/fendo.2020.00565","volume":"11","author":"M van Gerwen","year":"2020","unstructured":"van Gerwen, M. et al. Outcomes of patients with hypothyroidism and COVID-19: a retrospective cohort study. Front. Endocrinol. 11, 565 (2020).","journal-title":"Front. Endocrinol."},{"key":"946_CR86","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ijid.2022.01.016","volume":"116","author":"DN Pereira","year":"2022","unstructured":"Pereira, D. N. et al. Hypothyroidism does not lead to worse prognosis in COVID-19: findings from the Brazilian COVID-19 registry. Int. J. Infect. Dis. 116, 319\u2013327 (2022).","journal-title":"Int. J. Infect. Dis."},{"key":"946_CR87","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14699","author":"M Bogojevic","year":"2022","unstructured":"Bogojevic, M. et al. Association of hypothyroidism with outcomes in hospitalized adults with COVID-19: results from the International SCCM Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry.Clin. Endocrinol. https:\/\/doi.org\/10.1111\/cen.14699 (2022).","journal-title":"Clin. Endocrinol."},{"key":"946_CR88","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s40618-023-02048-w","volume":"46","author":"V Bagal\u00e0","year":"2023","unstructured":"Bagal\u00e0, V. et al. Clinical presentation and prognosis of COVID-19 in older adults with hypothyroidism: data from the GeroCovid observational study. J. Endocrinol. Invest. 46, 1891\u20131899 (2023).","journal-title":"J. Endocrinol. Invest."},{"key":"946_CR89","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1007\/s40618-022-01854-y","volume":"45","author":"DTW Lui","year":"2022","unstructured":"Lui, D. T. W. et al. Development of a prediction score (ThyroCOVID) for identifying abnormal thyroid function in COVID-19 patients. J. Endocrinol. Invest. 45, 2149\u20132156 (2022).","journal-title":"J. Endocrinol. Invest."},{"key":"946_CR90","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1210\/clinem\/dgab349","volume":"106","author":"SA Clarke","year":"2021","unstructured":"Clarke, S. A. et al. Normal adrenal and thyroid function in patients who survive COVID-19 infection. J. Clin. Endocrinol. Metab. 106, 2208\u20132220 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"946_CR91","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.eprac.2021.06.016","volume":"27","author":"DTW Lui","year":"2021","unstructured":"Lui, D. T. W. et al. Long COVID in patients with mild to moderate disease: do thyroid function and autoimmunity play a role? Endocr. Pract. 27, 894\u2013902 (2021).","journal-title":"Endocr. Pract."},{"key":"946_CR92","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s12020-022-03281-8","volume":"80","author":"DTW Lui","year":"2023","unstructured":"Lui, D. T. W. et al. A prospective follow-up on thyroid function, thyroid autoimmunity and long COVID among 250 COVID-19 survivors. Endocrine 80, 380\u2013391 (2023). A 6-month prospective follow-up study predominantly of patients with non-severe COVID-19 showing that COVID-19 did not lead to a substantial increase in incidence of thyroid dysfunction and thyroid autoimmunity.","journal-title":"Endocrine"},{"key":"946_CR93","doi-asserted-by":"publisher","first-page":"e803","DOI":"10.1210\/clinem\/dgaa830","volume":"106","author":"B Khoo","year":"2021","unstructured":"Khoo, B. et al. Thyroid function before, during, and after COVID-19. J. Clin. Endocrinol. Metab. 106, e803\u2013e811 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"946_CR94","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1530\/EJE-20-1391","volume":"184","author":"I Campi","year":"2021","unstructured":"Campi, I. et al. The spectrum of thyroid function tests during hospitalization for SARS COV-2 infection. Eur. J. Endocrinol. 184, 699\u2013709 (2021).","journal-title":"Eur. J. Endocrinol."},{"key":"946_CR95","first-page":"7","volume":"5","author":"A Goyal","year":"2022","unstructured":"Goyal, A., Gupta, Y., Kalaivani, M. & Tandon, N. Mild and asymptomatic SARS-CoV-2 infection is not associated with progression of thyroid dysfunction or thyroid autoimmunity. Clin. Endocrinol. 5, 7\u20139 (2022).","journal-title":"Clin. Endocrinol."},{"key":"946_CR96","doi-asserted-by":"publisher","first-page":"746602","DOI":"10.3389\/fendo.2021.746602","volume":"12","author":"DTW Lui","year":"2021","unstructured":"Lui, D. T. W. et al. The impact of interferon Beta-1b therapy on thyroid function and autoimmunity among COVID-19 survivors. Front. Endocrinol. 12, 746602 (2021).","journal-title":"Front. Endocrinol."},{"key":"946_CR97","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1080\/07435800.2023.2188086","volume":"48","author":"Z Alphan Uc","year":"2023","unstructured":"Alphan Uc, Z., Yagc\u0131, P., Adibelli, Z. & Duran, C. The spectrum of thyroid function tests and autoantibodies during hospitalization and after six months of discharge in COVID-19 patients: does COVID-19 trigger autoimmunity? Endocr. Res. 48, 44\u201354 (2023).","journal-title":"Endocr. Res."},{"key":"946_CR98","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-22-0200","volume":"12","author":"I Muller","year":"2023","unstructured":"Muller, I. et al. Long-term outcome of thyroid abnormalities in patients with severe Covid-19. Eur. Thyroid. J. 12, e220200 (2023). A prospective 12-month follow-up study predominantly of patients with severe COVID-19, which showed that all participants had normal thyroid function and normalization of levels of C-reactive protein upon follow-up.","journal-title":"Eur. Thyroid. J."},{"key":"946_CR99","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3803\/EnM.2023.1711","volume":"38","author":"J Lee","year":"2023","unstructured":"Lee, J., Seo, G. H. & Song, K. Beyond acute COVID-19: investigating the incidence of subacute thyroiditis in long COVID-19 in Korea. Endocrinol. Metab. 38, 455\u2013461 (2023).","journal-title":"Endocrinol. Metab."},{"key":"946_CR100","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s40618-021-01554-z","volume":"44","author":"G Lisco","year":"2021","unstructured":"Lisco, G. et al. Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects. J. Endocrinol. Invest. 44, 1801\u20131814 (2021).","journal-title":"J. Endocrinol. Invest."},{"key":"946_CR101","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.beem.2013.10.003","volume":"27","author":"O Koulouri","year":"2013","unstructured":"Koulouri, O., Moran, C., Halsall, D., Chatterjee, K. & Gurnell, M. Pitfalls in the measurement and interpretation of thyroid function tests. Best Pract. Res. Clin. Endocrinol. Metab. 27, 745\u2013762 (2013).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"946_CR102","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/COH.0000000000000652","volume":"15","author":"IFN Hung","year":"2020","unstructured":"Hung, I. F. N. Treatment of coronavirus disease 2019. Curr. Opin. HIV AIDS 15, 336\u2013340 (2020).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"946_CR103","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1002\/jmv.26976","volume":"93","author":"C Tortajada","year":"2021","unstructured":"Tortajada, C., A\u00f1\u00f3n, S., Ortiz, M. M., Andreu-Ballester, J. C. & Flores, J. Interferon \u03b2-1b for patients with moderate to severe COVID-19 in the inflammatory phase of the disease. J. Med. Virol. 93, 4102\u20134107 (2021).","journal-title":"J. Med. Virol."},{"key":"946_CR104","doi-asserted-by":"publisher","first-page":"101759","DOI":"10.1016\/j.beem.2023.101759","volume":"37","author":"SN \u015eendur","year":"2023","unstructured":"\u015eendur, S. N., O\u011fuz, S. H. & \u00dcnl\u00fct\u00fcrk, U. COVID-19 vaccination and thyroiditis. Best Pract. Res. Clin. Endocrinol. Metab. 37, 101759 (2023). A comprehensive review of the latest evidence on thyroiditis in relation to COVID-19 vaccination.","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"946_CR105","doi-asserted-by":"publisher","first-page":"938001","DOI":"10.3389\/fendo.2022.938001","volume":"13","author":"KK Triantafyllidis","year":"2022","unstructured":"Triantafyllidis, K. K., Giannos, P., Stathi, D. & Kechagias, K. S. Graves\u2019 disease following vaccination against SARS-CoV-2: a systematic review of the reported cases. Front. Endocrinol. 13, 938001 (2022).","journal-title":"Front. Endocrinol."},{"key":"946_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01210-7","volume":"28","author":"K Chen","year":"2023","unstructured":"Chen, K., Gao, Y. & Li, J. New-onset and relapsed Graves\u2019 disease following COVID-19 vaccination: a comprehensive review of reported cases. Eur. J. Med. Res. 28, 232 (2023).","journal-title":"Eur. J. Med. Res."},{"key":"946_CR107","first-page":"150","volume":"7","author":"A Watad","year":"2016","unstructured":"Watad, A., David, P., Brown, S. & Shoenfeld, Y. Autoimmune\/inflammatory syndrome induced by adjuvants and thyroid autoimmunity. Front. Endocrinol. 7, 150 (2016).","journal-title":"Front. Endocrinol."},{"key":"946_CR108","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1089\/thy.2022.0010","volume":"32","author":"SN \u015eendur","year":"2022","unstructured":"\u015eendur, S. N. et al. Association of human leukocyte antigen genotypes with severe acute respiratory syndrome coronavirus 2 vaccine-induced subacute thyroiditis. Thyroid 32, 640\u2013647 (2022).","journal-title":"Thyroid"},{"key":"946_CR109","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejim.2021.10.008","volume":"94","author":"A Kyriacou","year":"2021","unstructured":"Kyriacou, A., Ioakim, S. & Syed, A. A. COVID-19 vaccination and a severe pain in the neck. Eur. J. Intern. Med. 94, 95\u201396 (2021).","journal-title":"Eur. J. Intern. Med."},{"key":"946_CR110","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s40618-022-01747-0","volume":"45","author":"S Ippolito","year":"2022","unstructured":"Ippolito, S. et al. SARS-CoV-2 vaccine-associated subacute thyroiditis: insights from a systematic review. J. Endocrinol. Invest. 45, 1189\u20131200 (2022).","journal-title":"J. Endocrinol. Invest."},{"key":"946_CR111","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1210\/clinem\/dgac550","volume":"108","author":"L di Filippo","year":"2022","unstructured":"di Filippo, L. et al. Distinct clinical features of post-COVID-19 vaccination early-onset graves\u2019 disease. J. Clin. Endocrinol. Metab. 108, 107\u2013113 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"946_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02548-1","volume":"20","author":"CKH Wong","year":"2022","unstructured":"Wong, C. K. H. et al. Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients. BMC Med. 20, 339 (2022).","journal-title":"BMC Med."},{"key":"946_CR113","doi-asserted-by":"publisher","first-page":"e3781","DOI":"10.1210\/clinem\/dgac355","volume":"107","author":"DTW Lui","year":"2022","unstructured":"Lui, D. T. W. et al. Effect of COVID-19 vaccines on thyroid function and autoimmunity and effect of thyroid autoimmunity on antibody response. J. Clin. Endocrinol. Metab. 107, e3781\u2013e3789 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"946_CR114","doi-asserted-by":"publisher","first-page":"e508","DOI":"10.1210\/clinem\/dgad582","volume":"109","author":"A Gorshtein","year":"2023","unstructured":"Gorshtein, A., Turjeman, A., Duskin-Bitan, H., Leibovici, L. & Robenshtok, E. Graves\u2019 disease following COVID-19 vaccination: a population-based, matched case-control study. J. Clin. Endocrinol. Metab. 109, e508\u2013e512 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"946_CR115","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.eprac.2023.05.005","volume":"29","author":"M Endo","year":"2023","unstructured":"Endo, M. et al. The incidence of Graves\u2019 hyperthyroidism before and after COVID-19 messenger RNA vaccination. Endocr. Pract. 29, 618\u2013622 (2023).","journal-title":"Endocr. Pract."},{"key":"946_CR116","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1210\/clinem\/dgac684","volume":"108","author":"CH Wong","year":"2023","unstructured":"Wong, C. H. et al. Effect of inactivated and mRNA COVID-19 vaccination on thyroid function among patients treated for hyperthyroidism. J. Clin. Endocrinol. Metab. 108, e76\u2013e88 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"946_CR117","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1016\/j.vaccine.2023.07.053","volume":"41","author":"S Xu","year":"2023","unstructured":"Xu, S. et al. Inactivated SARS-CoV-2 vaccination does not disturb the clinical course of Graves\u2019 disease: an observational cohort study. Vaccine 41, 5648\u20135654 (2023).","journal-title":"Vaccine"},{"key":"946_CR118","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1089\/thy.2021.0684","volume":"32","author":"X Xiong","year":"2022","unstructured":"Xiong, X. et al. Safety of inactivated and mRNA COVID-19 vaccination among patients treated for hypothyroidism: a population-based cohort study. Thyroid 32, 505\u2013514 (2022).","journal-title":"Thyroid"},{"key":"946_CR119","doi-asserted-by":"publisher","first-page":"e1823","DOI":"10.1210\/clinem\/dgac049","volume":"107","author":"SH O\u011fuz","year":"2022","unstructured":"O\u011fuz, S. H. et al. SARS-CoV-2 vaccine-induced thyroiditis: safety of revaccinations and clinical follow-up. J. Clin. Endocrinol. Metab. 107, e1823\u2013e1834 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"946_CR120","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1210\/clinem\/dgac119","volume":"107","author":"YJ Chee","year":"2022","unstructured":"Chee, Y. J. et al. SARS-CoV-2 mRNA vaccination and Graves\u2019 disease: a report of 12 cases and review of the literature. J. Clin. Endocrinol. Metab. 107, 2324\u20132330 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"946_CR121","doi-asserted-by":"publisher","first-page":"1041676","DOI":"10.3389\/fendo.2022.1041676","volume":"13","author":"CL Rossetti","year":"2022","unstructured":"Rossetti, C. L. et al. COVID-19 and thyroid function: what do we know so far? Front. Endocrinol. 13, 1041676 (2022).","journal-title":"Front. Endocrinol."},{"key":"946_CR122","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1089\/thy.2020.0363","volume":"31","author":"M Chen","year":"2020","unstructured":"Chen, M., Zhou, W. & Xu, W. Thyroid function analysis in 50 patients with COVID-19: a retrospective study. Thyroid 31, 8\u201311 (2020).","journal-title":"Thyroid"},{"key":"946_CR123","unstructured":"National Institutes of Health. Clinical spectrum of SARS-CoV-2 infection. NIH https:\/\/www.covid19treatmentguidelines.nih.gov\/overview\/clinical-spectrum (2023)."},{"key":"946_CR124","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.eprac.2022.02.003","volume":"28","author":"R Pal","year":"2022","unstructured":"Pal, R. et al. Endocrine follow-up during post-acute COVID-19: practical recommendations based on available clinical evidence. Endocr. Pract. 28, 425\u2013432 (2022).","journal-title":"Endocr. Pract."},{"key":"946_CR125","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3803\/EnM.2021.404","volume":"36","author":"CR Ku","year":"2021","unstructured":"Ku, C. R. et al. COVID-19 vaccination for endocrine patients: a position statement from the Korean Endocrine Society. Endocrinol. Metab. 36, 757\u2013765 (2021).","journal-title":"Endocrinol. Metab."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-023-00946-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-023-00946-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-023-00946-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T09:03:18Z","timestamp":1715850198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-023-00946-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,12]]},"references-count":125,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["946"],"URL":"https:\/\/doi.org\/10.1038\/s41574-023-00946-w","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,12]]},"assertion":[{"value":"18 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}